Suitability of transiently expressed antibodies for clinical studies: product quality consistency at different production scales

• Main Authors: Sara Rodriguez-Conde (Author), Sophie Inman (Author), Viv Lindo (Author), Leanne Amery (Author), Alison Tang (Author), Uche Okorji-Obike (Author), Wenjuan Du (Author), Berend-Jan Bosch (Author), Paul J. Wichgers Schreur (Author), Jeroen Kortekaas (Author), Isabel Sola (Author), Luis Enjuanes (Author), Laura Kerry (Author), Katharina Mahal (Author), Martyn Hulley (Author), Olalekan Daramola (Author)
• Format: Book
• Published: Taylor & Francis Group, 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Transgenic human monoclonal antibodies derived from humanized mice against different epitopes of the Middle East respiratory syndrome coronavirus (MERS-CoV), and chimeric llama-human bispecific heavy chain-only antibodies targeting the Rift Valley fever virus (RVFV), were produced using a CHO-based...